Skin disorder
MONDO:0005093Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
Also known as: cutaneous disorder, disease of zone of skin, disease or disorder of zone of skin, disorder of skin, disorder of zone of skin, skin diseases and manifestations, skin disorder, zone of skin disease
3961 clinical trials for this condition and its sub-types, 138 tagged with Skin disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin disorder
-
Dermatitis 65 trials · 1,623 incl. sub-types
33 sub-types
- Atopic eczema 467 trials · 480 incl. sub-types Sub-types →
- Psoriasis 379 trials Sub-types →
- Urticaria 28 trials · 164 incl. sub-types Sub-types →
- Skin infection 12 trials · 152 incl. sub-types Sub-types →
- Dermatomyositis 81 trials · 100 incl. sub-types Sub-types →
- Vitiligo 100 trials Sub-types →
- Acne 91 trials Sub-types →
- Autoimmune bullous skin disease 7 trials · 55 incl. sub-types Sub-types →
- Lichen planus 19 trials · 47 incl. sub-types Sub-types →
- Radiodermatitis 37 trials · 42 incl. sub-types Sub-types →
- Contact dermatitis 9 trials · 24 incl. sub-types Sub-types →
- Lichen sclerosus et atrophicus 10 trials · 20 incl. sub-types Sub-types →
- Seborrheic dermatitis 15 trials Sub-types →
- Neurodermatitis 10 trials
- Folliculitis 1 trial · 8 incl. sub-types Sub-types →
- Cutaneous vasculitis 4 trials · 5 incl. sub-types Sub-types →
- Neurotic excoriation 5 trials
- Acanthosis nigricans 4 trials Sub-types →
- Acneiform dermatitis 4 trials
- Acrodermatitis 0 trials · 2 incl. sub-types Sub-types →
- Hydroa vacciniforme 2 trials Sub-types →
- Acute generalized exanthematous pustulosis 1 trial
- Exfoliative dermatitis 1 trial
- Granuloma annulare 1 trial
- Lipodermatosclerosis 1 trial
- Parapsoriasis 0 trials · 1 incl. sub-types Sub-types →
- Porphyria cutanea tarda 0 trials · 1 incl. sub-types Sub-types →
- Dermatosis papulosa nigra 0 trials
- Food dermatitis 0 trials
- Granulomatous dermatitis 0 trials
- Intertrigo 0 trials
- Pityriasis rosea 0 trials
- Spongiotic dermatitis 0 trials
-
Skin neoplasm 168 trials · 990 incl. sub-types
17 sub-types
- Skin cancer 117 trials · 798 incl. sub-types Sub-types →
- Melanocytic skin neoplasm 2 trials · 359 incl. sub-types Sub-types →
- Epithelial skin neoplasm 0 trials · 310 incl. sub-types Sub-types →
- Benign neoplasm of skin 3 trials · 117 incl. sub-types Sub-types →
- Dermis tumor 0 trials · 90 incl. sub-types Sub-types →
- Actinic keratosis 41 trials
- Epidermal appendage tumor 3 trials · 8 incl. sub-types Sub-types →
- Eyelid neoplasm 3 trials · 7 incl. sub-types Sub-types →
- Schwannomatosis 3 trials Sub-types →
- Maffucci syndrome 2 trials
- Benign dermal neurilemmoma 0 trials
- Calcifying epithelial odontogenic tumor 0 trials
- Dermoid cyst of skin 0 trials
- Familial Dupuytren contracture 0 trials
- Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 0 trials
- Familial multiple discoid fibromas 0 trials
- Hemangiopericytoma of skin 0 trials
-
Hereditary skin disorder 7 trials · 880 incl. sub-types
114 sub-types
- Psoriasis 379 trials Sub-types →
- Acne 91 trials Sub-types →
- Hereditary angioedema 58 trials · 60 incl. sub-types Sub-types →
- Ectodermal dysplasia syndrome 3 trials · 45 incl. sub-types Sub-types →
- CHILD syndrome 37 trials
- Inherited epidermolysis bullosa 5 trials · 37 incl. sub-types Sub-types →
- Inherited ichthyosis 6 trials · 32 incl. sub-types Sub-types →
- Hereditary photodermatosis 0 trials · 31 incl. sub-types Sub-types →
- Lichen sclerosus et atrophicus 10 trials · 20 incl. sub-types Sub-types →
- Hereditary lipodystrophy 2 trials · 17 incl. sub-types Sub-types →
- Hereditary palmoplantar keratoderma 0 trials · 13 incl. sub-types Sub-types →
- Familial multiple nevi flammei 12 trials
- Syndromic oculocutaneous albinism 0 trials · 12 incl. sub-types Sub-types →
- Cowden disease 11 trials Sub-types →
- Familial pityriasis rubra pilaris 10 trials
- Lentigo 8 trials
- Subcutaneous panniculitis-like T-cell lymphoma 8 trials
- Large congenital melanocytic nevus 7 trials
- Alopecia, isolated 0 trials · 6 incl. sub-types Sub-types →
- Neutrophil actin dysfunction 6 trials
- Seborrheic keratosis 6 trials Sub-types →
- CLOVES syndrome 5 trials
- Legius syndrome 5 trials
- Reticulate pigment disorder 0 trials · 5 incl. sub-types Sub-types →
- Chronic mucocutaneous candidiasis 4 trials Sub-types →
- Lamellar ichthyosis 4 trials Sub-types →
- Oculocutaneous albinism 4 trials Sub-types →
- Piebaldism 4 trials
- Hailey-Hailey disease 3 trials
- Aplasia cutis congenita 3 trials Sub-types →
- Hereditary mucosal leukokeratosis 3 trials Sub-types →
- Schwannomatosis 3 trials Sub-types →
- Maffucci syndrome 2 trials
- Sneddon syndrome 2 trials
- Autosomal dominant vibratory urticaria 2 trials
- Blue rubber bleb nevus 2 trials
- Familial chilblain lupus 2 trials Sub-types →
- Keratosis pilaris atrophicans 2 trials Sub-types →
- Stiff skin syndrome 2 trials Sub-types →
- Sweet syndrome 2 trials
- Tietz syndrome 1 trial
- X-linked chondrodysplasia punctata 2 1 trial
- Acrokeratosis verruciformis 1 trial
- Dyschromatosis universalis hereditaria 1 trial Sub-types →
- Familial primary localized cutaneous amyloidosis 1 trial Sub-types →
- Linear nevus sebaceous syndrome 1 trial
- Neurocutaneous melanocytosis 1 trial
- Nevus, epidermal 1 trial Sub-types →
- Urticaria, aquagenic 1 trial
- Urticaria, familial localized heat 1 trial
- Becker nevus syndrome 0 trials Sub-types →
- Cobb syndrome 0 trials
- DK1-congenital disorder of glycosylation 0 trials
- Darier disease 0 trials
- H syndrome 0 trials
- MEDNIK syndrome 0 trials
- PENS syndrome 0 trials
- VPS13A-related neurodegenerative disease 0 trials
- X-linked reticulate pigmentary disorder 0 trials
- Absence of fingerprints-congenital milia syndrome 0 trials
- Acrogeria 0 trials
- Albinism-hearing loss syndrome 0 trials
- Anhidrosis, familial generalized, with abnormal or absent sweat glands 0 trials
- Autosomal recessive cutis laxa type 2A 0 trials Sub-types →
- Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency 0 trials
- Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis 0 trials
- Combined immunodeficiency with skin granulomas 0 trials
- Deafness, congenital, with total albinism 0 trials
- Dermatitis herpetiformis, familial 0 trials
- Dermatosis papulosa nigra 0 trials
- Encephalocraniocutaneous lipomatosis 0 trials
- Epidermodysplasia verruciformis 0 trials Sub-types →
- Familial acanthosis nigricans 0 trials
- Familial acne inversa 0 trials Sub-types →
- Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome 0 trials
- Familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome 0 trials
- Familial keratoacanthoma 0 trials
- Familial multiple discoid fibromas 0 trials
- Familial multiple fibrofolliculoma 0 trials
- Generalized basaloid follicular hamartoma syndrome 0 trials
- Hereditary mucoepithelial dysplasia 0 trials
- Hereditary papulotranslucent acrokeratoderma 0 trials
- Hereditary sclerosing poikiloderma with tendon and pulmonary involvement 0 trials
- Hydroa vacciniforme, familial 0 trials
- Hyperkeratosis-hyperpigmentation syndrome 0 trials
- Hyperpigmentation with or without hypopigmentation, familial progressive 0 trials Sub-types →
- Inflammatory poikiloderma with hair abnormalities and acral keratoses 0 trials
- Infundibulocystic basal cell carcinoma 0 trials
- Isolated anhidrosis with normal sweat glands 0 trials
- Isolated congenital adermatoglyphia 0 trials
- Isolated hyperchlorhidrosis 0 trials
- Juvenile hyaline fibromatosis 0 trials
- Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome 0 trials
- Lichen planus, familial 0 trials
- Linear skin defects with multiple congenital anomalies 0 trials Sub-types →
- Lipoid proteinosis 0 trials
- Monilethrix 0 trials Sub-types →
- Multiple benign circumferential skin creases on limbs 1 0 trials
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Nevus comedonicus syndrome 0 trials
- Osteopathia striata-pigmentary dermopathy-white forelock syndrome 0 trials
- Phakomatosis pigmentokeratotica 0 trials
- Pilomatrixoma 0 trials
- Poikiloderma with neutropenia 0 trials
- Porokeratosis 0 trials Sub-types →
- Progressive osseous heteroplasia 0 trials
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Sebocystomatosis 0 trials
- Seborrhea-like dermatitis with psoriasiform elements 0 trials
- Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome 0 trials
- Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 0 trials
- Skin creases, congenital symmetric circumferential, 2 0 trials
- Spinocerebellar ataxia type 34 0 trials
- Vasculitis, lymphocytic, nodular 0 trials
-
Skin disorder caused by infection 3 trials · 349 incl. sub-types
15 sub-types
- Skin infection 12 trials · 152 incl. sub-types Sub-types →
- Herpes zoster 73 trials Sub-types →
- Skin disease caused by bacterial infection 13 trials · 57 incl. sub-types Sub-types →
- Parasitic skin disorder 1 trial · 37 incl. sub-types Sub-types →
- Chickenpox 26 trials
- Common wart 26 trials
- Virus-associated trichodysplasia spinulosa 10 trials
- Plantar wart 9 trials
- Hand, foot and mouth disease 7 trials
- Viral exanthem 0 trials · 3 incl. sub-types Sub-types →
- Epstein-Barr virus hepatitis 0 trials
- Exanthema subitum 0 trials
- Herpetic whitlow 0 trials
- Infective dermatitis associated with HTLV-1 0 trials
- Variola major infectious disease 0 trials
-
Systemic sclerosis 261 trials · 295 incl. sub-types
6 sub-types
- Diffuse scleroderma 82 trials
- Diffuse cutaneous systemic sclerosis 30 trials
- Pulmonary systemic sclerosis 27 trials
- Limited cutaneous systemic sclerosis 2 trials Sub-types →
- Limited systemic sclerosis 0 trials
- Scleroderma, familial progressive 0 trials
-
Chronic ulcer of skin 48 trials · 269 incl. sub-types
2 sub-types
- Decubitus ulcer 137 trials
- Ulcer of lower limbs 124 trials
-
Vesiculobullous skin disease 3 trials · 213 incl. sub-types
8 sub-types
- Herpes zoster 73 trials Sub-types →
- Autoimmune bullous skin disease 7 trials · 55 incl. sub-types Sub-types →
- Epidermolysis bullosa 23 trials · 44 incl. sub-types Sub-types →
- Cellulitis 29 trials · 31 incl. sub-types Sub-types →
- Chickenpox 26 trials
- Eosinophilic pustular folliculitis 1 trial Sub-types →
- Gas gangrene 0 trials
- Papular urticaria 0 trials
-
Sweat gland disorder 7 trials · 148 incl. sub-types
6 sub-types
- Apocrine sweat gland disorder 0 trials · 138 incl. sub-types Sub-types →
- Miliaria 7 trials Sub-types →
- Sweat gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Dyshidrosis 2 trials
- Anhidrosis 1 trial Sub-types →
- Fox-Fordyce disease 0 trials
-
Skin vascular disease 5 trials · 134 incl. sub-types
20 sub-types
- Angioedema 19 trials · 66 incl. sub-types Sub-types →
- Behcet disease 37 trials
- Familial multiple nevi flammei 12 trials
- Chilblain lupus 1 trial · 3 incl. sub-types Sub-types →
- Livedo reticularis 3 trials
- Maffucci syndrome 2 trials
- Sneddon syndrome 2 trials
- Blue rubber bleb nevus 2 trials
- Malignant atrophic papulosis 2 trials
- Pityriasis lichenoides 1 trial Sub-types →
- Bockenheimer syndrome 0 trials
- Cobb syndrome 0 trials
- Wyburn-Mason syndrome 0 trials
- Angioma serpiginosum 0 trials Sub-types →
- Atrophic papulosis 0 trials Sub-types →
- Calciphylaxis cutis 0 trials
- Cutaneous collagenous vasculopathy 0 trials
- Cutis marmorata telangiectatica congenita 0 trials
- Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome 0 trials
- Generalized essential telangiectasia 0 trials
-
Epidermal disease 0 trials · 128 incl. sub-types
25 sub-types
- Ichthyosis 13 trials · 40 incl. sub-types Sub-types →
- Inherited epidermolysis bullosa 5 trials · 37 incl. sub-types Sub-types →
- Palmoplantar pustulosis 22 trials
- Hereditary palmoplantar keratoderma 0 trials · 13 incl. sub-types Sub-types →
- Erythrokeratoderma 0 trials · 12 incl. sub-types Sub-types →
- Hailey-Hailey disease 3 trials
- Keratosis pilaris atrophicans 2 trials Sub-types →
- Aquagenic palmoplantar keratoderma 1 trial
- Hereditary poikiloderma 1 trial Sub-types →
- 13q12.3 microdeletion syndrome 0 trials
- Darier disease 0 trials
- VPS13A-related neurodegenerative disease 0 trials
- Absence of fingerprints-congenital milia syndrome 0 trials
- Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome 0 trials
- Congenital erosive and vesicular dermatosis 0 trials
- Hyperkeratosis lenticularis perstans 0 trials
- Keratolytic winter erythema 0 trials
- Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome 0 trials
- Neonatal inflammatory skin and bowel disease 0 trials Sub-types →
- Phrynoderma 0 trials
- Porokeratosis 0 trials Sub-types →
- Psoriasis 14, pustular 0 trials
- Punctate acrokeratoderma freckle-like pigmentation 0 trials
- Seborrhea-like dermatitis with psoriasiform elements 0 trials
- Zinc-responsive necrolytic acral erythema 0 trials
-
Dermis disorder 0 trials · 103 incl. sub-types
28 sub-types
- Dermis tumor 0 trials · 90 incl. sub-types Sub-types →
- Primary cutaneous amyloidosis 4 trials · 5 incl. sub-types Sub-types →
- Primary anetoderma 4 trials
- Mixed dermis disorder 0 trials · 3 incl. sub-types Sub-types →
- Elastoma 1 trial
- Annular erythema of infancy 0 trials
- Antecubital pterygium syndrome 0 trials
- Atrophoderma of Pierini and Pasini 0 trials
- Confetti-like macular atrophy 0 trials
- Dermochondrocorneal dystrophy 0 trials
- Elastoderma 0 trials
- Elastosis perforans serpiginosa 0 trials
- Familial anetoderma 0 trials
- Familial cutaneous collagenoma 0 trials
- Familial reactive perforating collagenosis 0 trials
- Isolated anhidrosis with normal sweat glands 0 trials
- Late-onset focal dermal elastosis 0 trials
- Lichen myxedematosus 0 trials Sub-types →
- Linear atrophoderma of Moulin 0 trials
- Linear focal dermal elastosis 0 trials
- Lipoid proteinosis 0 trials
- Mid-dermal elastolysis 0 trials
- Necrobiosis lipoidica 0 trials
- Papular elastorrhexis 0 trials
- Primary cutis verticis gyrata 0 trials Sub-types →
- Progressive osseous heteroplasia 0 trials
- Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa 0 trials
- White fibrous papulosis of the neck 0 trials
-
Sebaceous gland disorder 0 trials · 100 incl. sub-types
7 sub-types
- Acne 91 trials Sub-types →
- Internal hordeolum 1 trial · 6 incl. sub-types Sub-types →
- Sebaceous gland neoplasm 0 trials · 3 incl. sub-types Sub-types →
- Alopecia mucinosa 0 trials
- Demodicidosis of sebaceous gland 0 trials
- Rhinophyma 0 trials
- Sebocystomatosis 0 trials
-
Severe cutaneous adverse reaction 62 trials · 68 incl. sub-types
3 sub-types
-
Skin pigmentation disorder 12 trials · 63 incl. sub-types
4 sub-types
- Hyperpigmentation of the skin 17 trials · 31 incl. sub-types Sub-types →
- Hypopigmentation of the skin 2 trials · 21 incl. sub-types Sub-types →
- Reticulate pigment disorder 0 trials · 5 incl. sub-types Sub-types →
- Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome 0 trials
-
Lipodystrophy 30 trials · 48 incl. sub-types
5 sub-types
- Partial lipodystrophy 7 trials · 19 incl. sub-types Sub-types →
- Hereditary lipodystrophy 2 trials · 17 incl. sub-types Sub-types →
- Generalized lipodystrophy 8 trials · 11 incl. sub-types Sub-types →
- Acquired lipodystrophy 3 trials · 9 incl. sub-types Sub-types →
- Localized lipodystrophy 0 trials · 4 incl. sub-types Sub-types →
-
Lichen disease 0 trials · 47 incl. sub-types
2 sub-types
- Lichen planus 19 trials · 47 incl. sub-types Sub-types →
- Lichen nitidus 0 trials
-
Hereditary epidermal appendage anomaly 0 trials · 45 incl. sub-types
3 sub-types
- Ectodermal dysplasia syndrome 3 trials · 45 incl. sub-types Sub-types →
- Hereditary sebaceous gland anomaly 0 trials
- Isolated hyperchlorhidrosis 0 trials
-
Rosacea 32 trials
1 sub-type
- Rhinophyma 0 trials
-
Keratosis 5 trials · 30 incl. sub-types
9 sub-types
- Palmoplantar keratosis 4 trials · 16 incl. sub-types Sub-types →
- Seborrheic keratosis 6 trials Sub-types →
- Cholesteatoma 1 trial · 3 incl. sub-types Sub-types →
- Acrokeratosis verruciformis 1 trial
- Acquired keratosis 0 trials
- Hereditary papulotranslucent acrokeratoderma 0 trials
- Keratosis follicularis spinulosa decalvans 0 trials Sub-types →
- Porokeratosis 0 trials Sub-types →
- Trichostasis spinulosa 0 trials
-
Exanthem 11 trials · 28 incl. sub-types
13 sub-types
- Pityriasis simplex 6 trials
- Pityriasis versicolor 4 trials
- Prurigo 3 trials
- Viral exanthem 0 trials · 3 incl. sub-types Sub-types →
- Pityriasis lichenoides 1 trial Sub-types →
- Bacterial exanthem 0 trials
- Exanthema subitum 0 trials
- Pityriasis alba 0 trials
- Pityriasis amiantacea 0 trials
- Pityriasis folliculorum 0 trials
- Pityriasis rosea 0 trials
- Pityriasis steatoides 0 trials
- Variola major infectious disease 0 trials
-
Reactive cutaneous fibrous lesion 0 trials · 28 incl. sub-types
2 sub-types
- Keloid 25 trials · 26 incl. sub-types Sub-types →
- Skin tag 2 trials
-
Prurigo nodularis 26 trials
-
Toxic dermatosis 0 trials · 20 incl. sub-types
5 sub-types
- Toxic epidermal necrolysis 9 trials · 14 incl. sub-types Sub-types →
- Drug rash with eosinophilia and systemic symptoms 5 trials
- Acute generalized exanthematous pustulosis 1 trial
- Erythema multiforme major 0 trials
- Fixed pigmented erythema 0 trials
-
Pyoderma 2 trials · 16 incl. sub-types
5 sub-types
- Pyoderma gangrenosum 10 trials Sub-types →
- Impetigo 5 trials Sub-types →
- Carbuncle 1 trial
- Cutaneous diphtheria 0 trials
- Erythrasma 0 trials
-
Hand-foot syndrome 9 trials
-
Oral erosive lichen 5 trials
-
Sunburn 5 trials
-
Cutaneous mucinosis 2 trials · 5 incl. sub-types
5 sub-types
- Secondary catabolic mucinosis of skin 0 trials · 3 incl. sub-types Sub-types →
- Cutaneous focal mucinosis 0 trials Sub-types →
- Diffuse cutaneous mucinosis 0 trials
- Lichen myxedematosus 0 trials Sub-types →
- Scleredema adultorum 0 trials
-
Actinic prurigo 2 trials
-
Cutaneous sclerosis 2 trials
-
Erythema multiforme 2 trials
-
Keratosis pilaris 2 trials
1 sub-type
- Keratosis pilaris atrophicans 2 trials Sub-types →
-
Paronychia 2 trials
1 sub-type
- Herpetic whitlow 0 trials
-
Skin atrophy 2 trials
-
Skin sarcoidosis 2 trials
-
Wells syndrome 1 trial
-
Aquagenic pruritus 1 trial
-
Chronic actinic dermatitis 1 trial
-
Erythematosquamous dermatosis 1 trial
-
Hand dermatosis 1 trial
-
Livedoid vasculopathy 1 trial
-
Solar urticaria 1 trial
-
Achenbach syndrome 0 trials
-
Bazex-Dupre-Christol syndrome 0 trials
1 sub-type
-
Boudhina Yedes Khiari syndrome 0 trials
-
Nicolau syndrome 0 trials
-
Parana hard-skin syndrome 0 trials
-
Acquired kinky hair syndrome 0 trials
-
Ainhum 0 trials
-
Cheilitis glandularis 0 trials
-
Congenital lethal erythroderma 0 trials
-
Cutaneous pseudolymphoma 0 trials
-
Erythema palmare hereditarium 0 trials
-
Facial dermatosis 0 trials
1 sub-type
- Judge Misch wright syndrome 0 trials
-
Granuloma faciale 0 trials
-
Hematohidrosis 0 trials
-
Hyperglobulinemic purpura 0 trials
-
Leg dermatosis 0 trials
-
Mongolian spot 0 trials
-
2 sub-types
-
Nephrogenic systemic fibrosis 0 trials
-
Non-neoplastic nevus 0 trials
-
Pellagra 0 trials
-
Pityriasis rotunda 0 trials
-
Primary cutaneous plasmacytosis 0 trials
-
Scalp dermatosis 0 trials
-
Sclerema neonatorum 0 trials
Most studied deeper sub-types
-
New hope for rare blood cancer: experimental drug targets mast cells
Disease control Recruiting nowThis study tests an experimental drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by blocking a key protein that drives abnormal mast cell growth. About 140 adults with aggre…
Phase 2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New cream could ease painful skin condition
Disease control Recruiting nowThis early-stage trial tests a cream called ruxolitinib on people with hidradenitis suppurativa, a condition causing painful lumps under the skin. The study includes 24 adults and teens and focuses on safety and how much of the drug gets into the body. Participants apply the crea…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for kids with severe hair loss: baricitinib pill tested in major trial
Disease control Recruiting nowThis study tests whether baricitinib, a daily pill, can safely regrow hair in children aged 6 to 17 with severe alopecia areata (patchy hair loss). About 595 kids will receive either the drug or a placebo for 36 weeks, then all can get the drug for up to 2 years. The goal is to s…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new injection calm severe eczema when creams fall short?
Disease control Recruiting nowThis study tests whether an investigational drug called tilrekimig, given as injections alongside medicated creams or ointments, can improve moderate-to-severe eczema (atopic dermatitis) in people aged 12 and older. Participants will be randomly assigned to receive either tilreki…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new medication called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 participants will receive either the drug or a placebo to see if it reduces skin redness, thickness, and itching over 24 weeks. The goal is to find a saf…
Phase 2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New shot could help eczema sufferers who Don't respond to steroids
Disease control Recruiting nowThis Phase 3 study tests whether lebrikizumab, an injectable drug, can safely and effectively treat nummular eczema in adults who haven't gotten enough relief from topical steroids or can't use them. About 270 participants will receive either lebrikizumab or a placebo injection. …
Phase 3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New gel could ease blistering for skin disorder patients
Disease control Recruiting nowThis study tests a gel called TolaSure on people aged 4 and older with epidermolysis bullosa simplex, a condition that causes fragile skin and blisters. For the first 2 months, some participants get the gel and others get a placebo; then everyone gets the gel for another 2 months…
Phase 2 • Sponsor: BioMendics, LLC • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests whether IMG-007 can safely reduce eczema symptoms like itching and redness in adults with moderate-to-severe disease who haven't responded well to topical treatments. About 405 participants will receive either the drug or a placebo, and researchers will measure s…
Phase 2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New skin disease drug enters first human trials
Disease control Recruiting nowThis study tests a new drug called BG-A3004 for the first time in humans. It aims to check the drug's safety and how the body processes it in healthy volunteers and people with immune-related skin diseases. The study is split into two parts: single dose in healthy people and mult…
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Gene therapy gel targets rare blistering skin disease
Disease control Recruiting nowThis early study tests a new gene therapy gel called KB111 for Hailey-Hailey disease, a rare genetic condition that causes painful blisters and skin lesions. The gel uses a modified virus to deliver a working copy of the faulty gene directly to the skin. The trial enrolls about 7…
Early phase 1 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Donor immune cells aim to tame autoimmune attacks
Disease control Recruiting nowThis early-stage study tests a new treatment made from healthy donor immune cells (CAR T cells) for people with severe autoimmune diseases like lupus that haven't responded to standard therapies. The goal is to see if these cells can safely target and calm the overactive immune s…
Phase 1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New Light-Activated gel aims to clear precancerous skin spots
Disease control Recruiting nowThis study tests a reformulated gel (Levulan Kerastick) combined with blue light therapy to treat actinic keratosis, a common precancerous skin condition. About 160 adults with 4 to 8 mild-to-moderate spots on the face or bald scalp will receive either the active gel or a placebo…
Phase 3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New light therapy could zap precancerous arm spots
Disease control Recruiting nowThis study tests a reformulated cream (Levulan Kerastick) plus blue light therapy for actinic keratosis, a common precancerous skin condition. About 260 adults with 4-8 spots on one arm will receive either the active treatment or a placebo cream, followed by light exposure. The m…
Phase 3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Lab-Grown skin patch could heal wounds in 'Butterfly Children'
Disease control Recruiting nowThis study tests a new skin graft made from a patient's own cells, genetically modified to produce a missing protein. It aims to safely heal wounds in 9 people with recessive dystrophic epidermolysis bullosa (RDEB), a rare disease that causes fragile, blistering skin. The graft i…
Phase 1/2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a psoriasis drug heal these stubborn skin ulcers?
Disease control Recruiting nowThis study tests guselkumab (Tremfya), a drug already used for psoriasis, in 17 adults with pyoderma gangrenosum—a rare disease that leads to painful, hard-to-heal skin ulcers. Participants receive injections every 4 weeks for 28 weeks. Researchers will check if ulcers heal compl…
Phase 2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Smart antibody monitoring could prevent pemphigus Flare-Ups
Disease control Recruiting nowThis study tests a personalized approach to treating pemphigus, a rare blistering skin disease. Instead of waiting for a relapse, doctors will use blood tests to measure specific antibodies and give extra rituximab infusions only when those levels rise. The goal is to prevent fla…
Phase 4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could 5 radiation sessions be as good as 30 for skin cancer?
Disease control Recruiting nowThis study tests whether a shorter, more intense type of radiation (stereotactic radiotherapy given in 5 sessions) works as well as the standard longer course (20-30 sessions) for treating skin cancer that has spread to the parotid gland in the head and neck. About 90 adults who …
Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New gel could help heal wounds in rare skin disease
Disease control Recruiting nowThis study tests a gel called Oleogel-S10 on skin wounds in people with inherited epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. The trial includes 6 Japanese children and adults with junctional or dystrophic EB. Participants apply the gel to wounds…
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug hope for stubborn hives patients
Disease control Expanded accessThis program provides remibrutinib, an experimental drug, to adults with chronic spontaneous urticaria (long-term hives) that haven't improved with antihistamines or omalizumab. Participants take the drug as prescribed to help control their symptoms. The goal is to offer access t…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New light scanner could spot skin cancer without a knife
Diagnosis Recruiting nowThis study tests a new, non-invasive imaging device that uses red light to look at skin lesions. Researchers want to see if it can help doctors diagnose skin cancer without needing a biopsy. The study will enroll 10 adults with skin lesions at Emory University.
Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
AI reads your skin: new tool aims to help doctors spot rashes and moles
Diagnosis Recruiting nowThis study is testing a software tool called Belle.ai that uses artificial intelligence to help doctors diagnose common skin diseases. About 400 patients at dermatology clinics will have three photos taken of their skin condition. The AI will analyze the photos and suggest possib…
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New drug aims to calm stubborn hives triggered by cold or scratching
Symptom relief Recruiting nowThis early-stage study tests a single dose of an experimental drug called GTX-B001 in healthy people and those with chronic inducible urticaria—a condition where cold or scratching causes painful hives. The main goal is to check safety and how the body handles the drug. About 72 …
Phase 1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New hope for painful skin condition: experimental drug LAD328 enters phase 2 trial
Symptom relief Recruiting nowThis study tests whether the experimental drug LAD328 can reduce symptoms of hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 50 adults with moderate-to-severe disease will receive either LAD328 or a placebo. The main goal is to see if the drug lead…
Phase 2 • Sponsor: Almirall, S.A. • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can an existing drug calm the itch of rare genetic skin diseases?
Symptom relief Recruiting nowThis early-phase study is testing whether dupilumab, a drug already used for eczema, can reduce severe itching in people with various genetic skin disorders. The trial will enroll 30 participants and last 26 months, including a 16-week treatment period and a longer extension phas…
Early phase 1 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Can a daily sachet give you brighter skin? new trial seeks answers
Symptom relief Recruiting nowThis study is testing whether a liquid supplement containing vitamin C and glutathione can improve skin tone, reduce spots, and boost hydration. Thirty healthy adults will take one sachet daily for 12 weeks. Researchers will measure changes in skin color, visible and UV spots, an…
Sponsor: TCI Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Scientists seek skin samples to unlock disease secrets
Knowledge-focused Recruiting nowThis study collects biological samples—like blood, skin biopsies, and swabs—from people with or at risk for skin diseases, as well as healthy volunteers. Researchers will use these samples to study the causes of skin conditions and explore potential treatments. Up to 700 particip…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists probe how eczema drugs alter skin microbes
Knowledge-focused Recruiting nowThis study examines how common eczema treatments, including antibiotics and bleach baths, change the types and amounts of bacteria on the skin. Researchers will compare people with eczema to healthy volunteers. The goal is to understand the skin microbiome better, not to test a n…
Phase 2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New camera-like device could help doctors see tissue health without cutting
Knowledge-focused Recruiting nowThis study is testing a new imaging tool called OCT Vibrography that measures how stiff or flexible tissues like the cornea, skin, and gums are. About 90 healthy volunteers will have the device used on them to see if it works safely. No treatment or medication is involved—just ob…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Skin clues could unmask rare nerve disease in kids
Knowledge-focused Recruiting nowThis study looks at children under 15 with neurofibromatosis type 2 (NF2), a rare genetic condition that causes nerve tumors. Researchers want to see if skin and mouth lesions can help diagnose NF2 earlier than current methods, which rely on hearing, nerve, and eye symptoms. By e…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI reads your symptom stories to find hidden medical clues
Knowledge-focused Recruiting nowThis study collects anonymous symptom descriptions from 1,000 adults through an online platform. An AI tool then searches medical literature to see if it can find reliable biological signals in the free-text descriptions. The goal is to test how accurate and consistent the AI's f…
Sponsor: OpenGenome • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
100,000 volunteers needed to unlock secrets of chronic diseases
Knowledge-focused Recruiting nowThis study is collecting health information, lifestyle data, and biological samples from up to 100,000 adults to help researchers better understand diseases like lupus, celiac disease, and kidney disease. Participants provide data and samples through a direct-to-patient platform.…
Sponsor: Joined Bio • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists probe blood vessel role in skin disorders
Knowledge-focused Recruiting nowThis study looks at how abnormal blood vessel growth (angiogenesis) contributes to various skin diseases like rosacea, psoriasis, and certain tumors. Researchers will collect skin samples from 85 volunteers aged 16 and older to analyze markers of angiogenesis. The goal is to bett…
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Scientists launch hunt for clues in autoimmune skin diseases
Knowledge-focused Recruiting nowThis study aims to create a large collection of blood samples and medical information from 800 people with autoimmune or inflammatory skin diseases. Researchers will use these samples to find new biomarkers and better understand what causes these conditions. The goal is to help d…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Scientists hunt for clues to better diagnose triggered hives
Knowledge-focused Recruiting nowThis study aims to find biological markers (biomarkers) that can help diagnose and monitor chronic induced urticaria (CIndU), a condition where specific triggers like cold or pressure cause itchy hives or swelling. Researchers will compare 40 participants—including people with CI…
Sponsor: Centre for Human Drug Research, Netherlands • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Burns disrupt skin and gut bacteria – scientists track the fallout
Knowledge-focused Recruiting nowThis study follows 600 burn patients and 60 healthy people over two years to see how burns change the community of microbes on the skin and in the gut. Researchers will collect swabs, stool, and blood samples at several time points to map these changes. The goal is to better unde…
Sponsor: Cho Yoon soo • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Tiny study hopes to unlock genetic secrets of rare skin condition
Knowledge-focused Recruiting nowThis study is looking for the gene or genes that cause cutis tricolor, a rare skin condition with patches of different colors. Researchers will analyze DNA from blood and skin samples of 10 patients and their parents. The goal is to find genetic changes that might explain the con…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
500 patients to reveal which chemo port dressings cause skin problems
Knowledge-focused Recruiting nowThis study will follow 500 adults starting chemotherapy with a chest port (a small device under the skin to deliver drugs). The goal is to measure how often skin reactions like itching or redness happen from the dressing that covers the port. Researchers will also look for factor…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:02 UTC